Retrospective Comparison of Andexanet Alfa and 4-Factor Prothrombin Complex for Reversal of Factor Xa-Inhibitor Related Bleeding

The aim of this retrospective study was to compare andexanet alfa and 4-factor prothrombin complex (4F-PCC) for reversal of factor Xa (FXa)-inhibitor bleeding. Patients that received andexanet alfa for reversal were included. An equivalent number of patients administered 4F-PCC for FXa-inhibitor ble...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevens, Victoria M., Trujillo, Toby C., Kiser, Tyree H., MacLaren, Robert, Reynolds, Paul M., Mueller, Scott W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642040/
https://www.ncbi.nlm.nih.gov/pubmed/34541920
http://dx.doi.org/10.1177/10760296211039020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8642040/
https://www.ncbi.nlm.nih.gov/pubmed/34541920
http://dx.doi.org/10.1177/10760296211039020

Ejemplares similares